Read the Full Research Overview
I knew the results I wanted to achieve and Mandie knew exactly how to achieve them
Although DSIP has demonstrated some promise as an antioxidant, antiedemic, and anticonvulsant agent, the research to date has been limited to animal studies, so its uncertain whether desired health outcomes are attainable in humans
Phases I and II are where the project comes to life, and hopefully, where the SBIR programs mission statement in regards to innovation is realized
Researchers examine how the combination affects collagen deposition, angiogenesis, inflammatory resolution, and functional recovery in experimental systems of tendon/ligament injury, muscle damage, ulcer models, and other tissue repair scenarios